Battle Of The OVERPRICED Appetite Suppressants | Tesofensine Vs. Tirzepatide (Mounjaro)

Name: Battle Of The OVERPRICED Appetite Suppressants | Tesofensine Vs. Tirzepatide (Mounjaro)
Uploaded: 2023-03-01T00:00:00
Description: Compares tesofensine (SNDRI) vs. tirzepatide (GLP-1/GIP agonist) for appetite suppression. Covers mechanisms, dosing, side effects, and personal efficacy results from a 2.5-week trial.

30 min read

Medical Disclaimer: This content is for educational purposes only and is not medical advice. Consult a qualified professional for medical decisions.

Video Info

Duration:0:00

Published:March 1, 2023

Category:tirzepatide

Battle Of The OVERPRICED Appetite Suppressants | Tesofensine Vs. Tirzepatide (Mounjaro)

Description

Full Transcript

AI-Generated Article

Video Info